logo
Select company
Select metric
$ 237.65MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
4
Sector
4
Industry
6
History
-
$ 23.95Close
$ 6.43 - $ 27.76 52-Week Range
Ticker Information

Ticker

ZBIO

Company Name

ZENAS BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ZENAS BIOPHARMA INC - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ZBIO - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 237.65M
12/31/2024$ 234.58M
12/31/2023$ 116K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ZENAS BIOPHARMA INC's latest trailing twelve months (TTM) CF - Equity stands at $ 116K.
  • Over the past 5 years, ZENAS BIOPHARMA INC's average CF - Equity has been $ 157.45M.
  • The median CF - Equity for ZENAS BIOPHARMA INC during this period was $ 234.58M
  • ZENAS BIOPHARMA INC reached its highest CF - Equity over the past 5 years at $ 237.65M.
  • The lowest CF - Equity recorded by ZENAS BIOPHARMA INC in the same timeframe $ 116K

ZENAS BIOPHARMA INC's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
ABUS : ARBUTUS BIOPHARMA CORP $ 6.43MQURE : UNIQURE NV $ 82.79MNUVB : NUVATION BIO INC $ 5.21MVIR : VIR BIOTECHNOLOGY INC $ 4.33MBCYC : BICYCLE THERAPEUTICS PLC $ 181KIMNM : IMMUNOME INC $ 193.92MRLAY : RELAY THERAPEUTICS INC $ 220.34MCAPR : CAPRICOR THERAPEUTICS INC $ 148.48MTSHA : TAYSHA GENE THERAPIES INC $ 222.61MALMS : ALUMIS INC $ 234.12M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

ZBIO - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ 116K

Minimum

Dec 31, 2023

$ 237.65M

Maximum

Jun 30, 2025

$ 157.45M

Average

$ 234.58M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 124.49K with a standard deviation of $ 17.66M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.9K
min$ -60.59M
max$ 60.64M
average$ 124.49K
median$ 0
std$ 17.66M